FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2759589726> ?p ?o ?g. }

• W2759589726 endingPage "1589" @default.
• W2759589726 startingPage "1589" @default.
• W2759589726 abstract "Doxorubicin (Dox) is an effective chemotherapeutic agent used in the treatment of various cancers. Its clinical use is often limited due to its potentially fatal cardiotoxic side effect. Increasing evidence indicates that tumour protein p53 (p53), adenosine monophosphate-activated protein kinase (AMPK), nucleoporin p62 (p62), and the mammalian target of rapamycin (mTOR) are critical mediators of Dox-induced apoptosis, and subsequent dysregulation of autophagy. Aspalathin, a polyphenolic dihydrochalcone C-glucoside has been shown to activate AMPK while decreasing the expression of p53. However, the role that aspalathin could play in the inhibition of Dox-induced cardiotoxicity through increased autophagy flux remained unexplored. H9c2 cardiomyocytes and Caov-3 ovarian cancer cells were cultured in Dulbecco’s Modified Eagle’s medium and treated with or without Dox for five days. Thereafter, cells exposed to 0.2 µM Dox were co-treated with either 20 µM Dexrazozane (Dexra) or 0.2 µM aspalathin (ASP) daily for 5 days. Results obtained showed that ASP mediates its cytoprotective effect in a p53-dependent manner, by increasing the Bcl-2/Bax ratio and decreasing apoptosis. The latter effect was diminished through ASP-induced activation of autophagy-related genes (Atgs) with an associated decrease in p62 through induction of AMPK and Fox01. Furthermore, we showed that ASP was able to potentiate this effect without decreasing the anti-cancer efficacy of Dox, as could be observed in Caov-3 ovarian cancer cells. Taken together, the data presented in this study provides a credible mechanism by which ASP co-treatment could protect the myocardium from Dox-induced cardiotoxicity." @default.
• W2759589726 created "2017-10-06" @default.
• W2759589726 creator A5006611112 @default.
• W2759589726 creator A5014988741 @default.
• W2759589726 creator A5037704297 @default.
• W2759589726 creator A5084293001 @default.
• W2759589726 creator A5085951889 @default.
• W2759589726 date "2017-09-22" @default.
• W2759589726 modified "2023-10-13" @default.
• W2759589726 title "Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling" @default.
• W2759589726 cites W1232687017 @default.
• W2759589726 cites W1508661542 @default.
• W2759589726 cites W1523693806 @default.
• W2759589726 cites W1935007110 @default.
• W2759589726 cites W1966995952 @default.
• W2759589726 cites W1970637701 @default.
• W2759589726 cites W1979562942 @default.
• W2759589726 cites W1982181214 @default.
• W2759589726 cites W1983568583 @default.
• W2759589726 cites W2001675597 @default.
• W2759589726 cites W2003059814 @default.
• W2759589726 cites W2003087616 @default.
• W2759589726 cites W2009891171 @default.
• W2759589726 cites W2019974695 @default.
• W2759589726 cites W2030926513 @default.
• W2759589726 cites W2034132952 @default.
• W2759589726 cites W2050332830 @default.
• W2759589726 cites W2059738518 @default.
• W2759589726 cites W2074934283 @default.
• W2759589726 cites W2080771381 @default.
• W2759589726 cites W2084304742 @default.
• W2759589726 cites W2086469250 @default.
• W2759589726 cites W2088355841 @default.
• W2759589726 cites W2088856765 @default.
• W2759589726 cites W2096308078 @default.
• W2759589726 cites W2112357840 @default.
• W2759589726 cites W2123368352 @default.
• W2759589726 cites W2192294917 @default.
• W2759589726 cites W2234413403 @default.
• W2759589726 cites W2238800297 @default.
• W2759589726 cites W2327259730 @default.
• W2759589726 cites W2327362588 @default.
• W2759589726 cites W2549329728 @default.
• W2759589726 cites W2572576786 @default.
• W2759589726 cites W2580657644 @default.
• W2759589726 cites W2584060009 @default.
• W2759589726 cites W2604555357 @default.
• W2759589726 cites W2610800734 @default.
• W2759589726 doi "https://doi.org/10.3390/molecules22101589" @default.
• W2759589726 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6151817" @default.
• W2759589726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28937626" @default.
• W2759589726 hasPublicationYear "2017" @default.
• W2759589726 type Work @default.
• W2759589726 sameAs 2759589726 @default.
• W2759589726 citedByCount "43" @default.
• W2759589726 countsByYear W27595897262017 @default.
• W2759589726 countsByYear W27595897262018 @default.
• W2759589726 countsByYear W27595897262019 @default.
• W2759589726 countsByYear W27595897262020 @default.
• W2759589726 countsByYear W27595897262021 @default.
• W2759589726 countsByYear W27595897262022 @default.
• W2759589726 countsByYear W27595897262023 @default.
• W2759589726 crossrefType "journal-article" @default.
• W2759589726 hasAuthorship W2759589726A5006611112 @default.
• W2759589726 hasAuthorship W2759589726A5014988741 @default.
• W2759589726 hasAuthorship W2759589726A5037704297 @default.
• W2759589726 hasAuthorship W2759589726A5084293001 @default.
• W2759589726 hasAuthorship W2759589726A5085951889 @default.
• W2759589726 hasBestOaLocation W27595897261 @default.
• W2759589726 hasConcept C126322002 @default.
• W2759589726 hasConcept C178790620 @default.
• W2759589726 hasConcept C184235292 @default.
• W2759589726 hasConcept C185592680 @default.
• W2759589726 hasConcept C190283241 @default.
• W2759589726 hasConcept C203522944 @default.
• W2759589726 hasConcept C2776694085 @default.
• W2759589726 hasConcept C2778233292 @default.
• W2759589726 hasConcept C2780124434 @default.
• W2759589726 hasConcept C2781303535 @default.
• W2759589726 hasConcept C29730261 @default.
• W2759589726 hasConcept C502942594 @default.
• W2759589726 hasConcept C55493867 @default.
• W2759589726 hasConcept C71924100 @default.
• W2759589726 hasConcept C75217442 @default.
• W2759589726 hasConcept C86554907 @default.
• W2759589726 hasConcept C97029542 @default.
• W2759589726 hasConcept C98274493 @default.
• W2759589726 hasConceptScore W2759589726C126322002 @default.
• W2759589726 hasConceptScore W2759589726C178790620 @default.
• W2759589726 hasConceptScore W2759589726C184235292 @default.
• W2759589726 hasConceptScore W2759589726C185592680 @default.
• W2759589726 hasConceptScore W2759589726C190283241 @default.
• W2759589726 hasConceptScore W2759589726C203522944 @default.
• W2759589726 hasConceptScore W2759589726C2776694085 @default.
• W2759589726 hasConceptScore W2759589726C2778233292 @default.
• W2759589726 hasConceptScore W2759589726C2780124434 @default.
• W2759589726 hasConceptScore W2759589726C2781303535 @default.
• W2759589726 hasConceptScore W2759589726C29730261 @default.

• next